ARMEN B. SHANAFELT, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Protagonist Therapeutics, Inc

Filing Date Source Excerpt
2017-04-24 Dr. Shanafelt received his B.S. in Chemistry and Physics from Pacific Lutheran University, and his Ph.D. in Chemistry from the University of California, Berkeley. He completed his postdoctoral work at DNAX Research Institute.
2018-04-18 Dr. Shanafelt received his B.S. in Chemistry and Physics from Pacific Lutheran University, and his Ph.D. in Chemistry from the University of California, Berkeley. He completed his postdoctoral work at DNAX Research Institute, where he studied the structure-function relationships of cytokines and their receptors.

Rein Therapeutics, Inc.

Filing Date Source Excerpt
2018-04-30 "Dr. Shanafelt received a B.S. from Pacific Lutheran University and a Ph.D. from the University of California, Berkeley."
2019-04-30 "Class II is comprised of Armen B. Shanafelt, Ph.D...."

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-04